You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET mutation

Showing 1 - 25 of 2,715
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

Recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • Toripalimab
  • +3 more
  • Guanzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Apr 4, 2023

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Irvine, California
  • +15 more
Mar 9, 2022

Vandetanib in RET -/+ Metastatic Medullary Thyroid Cancer

Completed
  • Symptomatic, Aggressive, Sporadic, Unresectable, Locally
  • Advanced/Metastatic Medullary Thyroid Cancer (MTC)
  • Vandetanib 300 mg
  • Belgium, Belgium
  • +7 more
Oct 15, 2020

Non Small Cell Lung Cancer, Ovarian Cancer, RET Gene Mutation Trial in New York (RXDX-105)

Completed
  • Non Small Cell Lung Cancer
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center 1275 York Avenue
Sep 30, 2020

Advanced Solid Tumor Trial in Los Angeles (EP0031)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +3 more
Dec 1, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

Recruiting
  • Non-small Cell Lung Cancer
  • London, United Kingdom
    Univeristy College London Hospital
Feb 22, 2022

Advanced Solid Tumor Trial in Chengdu (KL590586 Capsule)

Enrolling by invitation
  • Advanced Solid Tumor
  • KL590586 Capsule
  • Chengdu, Sichuan, China
    Sichuan Kelun Botai Biopharmaceutical Co.
Feb 23, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Metastatic Sporadic Medullary Thyroid Cancer Patients and

Completed
  • Metastatic Sporadic Medullary Thyroid Cancer
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
    Sep 29, 2021

    ALK-positive NSCLC (NSCLC), RET-positive NSCLC (NSCLC), RET-positive Thyroid Cancer Trial in Irvine, Boston (Alectinib)

    Terminated
    Has Results
    • ALK-positive Non-small Cell Lung Cancer (NSCLC)
    • +2 more
    • Irvine, California
    • +3 more
    Aug 30, 2021

    Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

    Recruiting
    • Cancer
    • +15 more
    • Data collection and quality of life questionnaire
    • Graz, Austria
    • +40 more
    Jul 27, 2021

    Cervical/Supraclavicular Metastasis From Non-small-cell Lung

    Recruiting
    • Lung Cancer Metastatic
    • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
    • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
    • Roma, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Jan 23, 2023

    Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

    Recruiting
    • Rare Tumor
    • Refractory Tumor
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Feb 16, 2022

    Efficacy of Immunotherapy With Rare Mutations in Non-small Cell

    Recruiting
    • Non Small Cell Lung Cancer
    • immunity therapy
    • Changsha, Hunan, China
    • +1 more
    Feb 28, 2022

    Resistance-associated Mutations in Metastatic Lung Cancer

    Recruiting
    • Lung Cancer
    • Liquid biopsy
    • Monza, MB, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    Oct 10, 2023

    Advanced Solid Tumor Trial in Shanghai (HS269)

    Not yet recruiting
    • Advanced Solid Tumor
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 24, 2021

    China With Non-Small-Cell Lung Cancer That is Unable to be

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      May 16, 2023

      Advanced Solid Tumor Trial in Changsha (IBI363)

      Not yet recruiting
      • Advanced Solid Tumor
      • Changsha, Hunan, China
        Yongchang Zhang
      Oct 12, 2023

      NSCLC Trial in Wuhan (Toripalimab, Anlotinib, SBRT 7Gy??5 QD)

      Recruiting
      • NSCLC
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Nov 29, 2021

      Hirschsprung Disease Genetic Study

      Recruiting
      • Hirschsprung Disease
      • Identification of genetic causes of Hirschsprung Disease
      • New York, New York
        New York University School of Medicine
      Jan 26, 2023